{"id":"W3173878348","doi":"10.1111/bjd.20595","title":"Long‐term efficacy and safety of risankizumab for the treatment of moderate‐to‐severe plaque psoriasis: interim analysis of the LIMMitless open‐label extension trial beyond 3 years of follow‐up","year":2021,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":49,"is_retracted":false,"has_abstract":true,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Psoriasis Area and Severity Index; Medicine; Dermatology Life Quality Index; Psoriasis; Discontinuation; Adverse effect; Internal medicine; Randomized controlled trial; Quality of life (healthcare); Dermatology; Surgery","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002092789,0.0001611589,0.001307222,0.000165988,0.0001050523,0.00001375063,0.0003830074,0.0002278622,0.00006092806],"category_scores_gemma":[0.000156434,0.0001197183,0.000447157,0.0003330662,0.000225784,0.00006778471,0.0001230908,0.0001017166,5.638913e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003270622,"about_ca_system_score_gemma":0.0002167858,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001214189,"about_ca_topic_score_gemma":0.0004636182,"domain_scores_codex":[0.9979694,0.0005019419,0.001051069,0.0002087074,0.00007407756,0.000194772],"domain_scores_gemma":[0.9974996,0.0008302384,0.0009415904,0.000323644,0.0003749414,0.00002997041],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.2344458,0.008663705,0.01666078,0.0002202747,0.04807331,0.0005663924,0.006014014,0.0002388447,0.09956407,0.0004195633,0.002031388,0.5831019],"study_design_scores_gemma":[0.2771021,0.004723531,0.2618932,0.0008567767,0.01970441,0.0108949,0.00137255,0.00003528668,0.4216505,0.0002077415,0.001134072,0.000424928],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9804001,0.01724858,0.0002550202,0.0002194403,0.0009017487,0.0005786125,0.0003731069,0.000002048969,0.00002134127],"genre_scores_gemma":[0.9951794,0.004378894,0.0001962792,0.00002707262,0.00002199724,0.00001760827,0.00004358539,0.00001338352,0.0001217457],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5826769,"threshold_uncertainty_score":0.4881971,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03393482954166807,"score_gpt":0.2914853224965989,"score_spread":0.2575504929549308,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}